STERIS plc (STE) stock
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 21/303% below fair value
$253.44−2.83 (-1.10%)
Close on Nov 12, 2026Market cap $24.71BP/E 30.1Yield 0.97%
Steris cash
Cash and short-term investments held at the end of each period.
Steris's cash was $531.10M at Sep 30, 2026. For fiscal 2026 it was $439.60M, up 156.0% from the year before. Over ten years it grew 5.9% a year on average. The highest annual figure on record is $439.60M in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $439.60M | +156.0% |
| FY2025 | Mar 31, 2025 | $171.70M | -17.1% |
| FY2024 | Mar 31, 2024 | $207.00M | -0.7% |
| FY2023 | Mar 31, 2023 | $208.40M | -40.2% |
| FY2022 | Mar 31, 2022 | $348.32M | +57.9% |
| FY2021 | Mar 31, 2021 | $220.53M | -31.0% |
| FY2020 | Mar 31, 2020 | $319.58M | +44.8% |
| FY2019 | Mar 31, 2019 | $220.63M | +9.5% |
| FY2018 | Mar 31, 2018 | $201.53M | -28.8% |
| FY2017 | Mar 31, 2017 | $282.92M | +13.7% |
| FY2016 | Mar 31, 2016 | $248.84M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | $531.10M | +66.4% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $482.30M | +72.4% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $439.60M | +156.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $423.70M | +173.0% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $319.20M | +85.4% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $279.70M | +41.0% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $171.70M | -17.1% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $155.20M | -20.6% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $172.20M | -19.4% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $198.30M | -4.9% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $207.00M | -0.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $195.59M | -24.6% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $213.76M | -17.2% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $208.61M | -34.1% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $208.40M | -40.2% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $259.37M | -27.8% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $258.26M | -32.7% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $316.33M | -40.8% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $348.32M | +57.9% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $359.09M | +42.2% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $383.49M | +22.9% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $534.77M | +109.2% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $220.53M | -31.0% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $252.50M | +26.7% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $312.03M | +38.3% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $255.63M | +7.4% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $319.58M | +44.8% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $199.23M | -11.4% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $225.54M | +7.4% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $238.07M | +8.9% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $220.63M | +9.5% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $224.91M | -20.5% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $209.92M | -15.6% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $218.52M | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $201.53M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $282.92M | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $248.84M | – |
See a number that looks wrong?